AVIR Reports $12.3M Q4 Rev, $0.08 EPS, Advances HCV Phase 3, AT-587 Mid-2026, $50M Buyback
Atea Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $4.38
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS